Latest news with #PRIME
Yahoo
a day ago
- Business
- Yahoo
Neuralink secures $650m in Series E to advance brain implant technology
Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant technology. This latest financial boost is aimed at expanding the reach of the company's devices, which are said to restore independence for individuals with severe medical conditions. The round saw contributions from a host of investors, including DFJ Growth, ARK Invest, Founders Fund, Human Capital, G42, Lightspeed, QIA, Thrive Capital, Sequoia Capital, Valor Equity Partners, and Vy Capital. Since its Series D round in August 2023, Elon Musk's Neuralink has been advancing the development of brain interfaces. According to the company, currently, five people with severe paralysis utilise Neuralink's technology to control various digital and physical devices using their thoughts alone. The company's trials are underway at neurosurgical care institutions across three countries on two continents. These comprise the Miami Project to Cure Paralysis at the University of Miami, US, the Barrow Neurological Institute, US, the Cleveland Clinic Abu Dhabi, and the University Health Network (Toronto Western Hospital), Canada. Neuralink invested in enhancing the device's interaction with a greater number of neurons and brain areas to unveil new potential dimensions. The fresh funding is set to expedite the company's drive to broaden access to patients and develop future solutions that bridge the gap between biological intelligence and AI. Musk has shifted focus back to his ventures, including Neuralink, Tesla, SpaceX, and xAI, after stepping down as a special adviser to US President Donald Trump. Last November, Neuralink secured approval for the CONVOY trial to study the brain implant with an assistive robotic arm, alongside the PRIME study in the US. Additionally, Health Canada approved Neuralink's first global trial, CAN-PRIME, to assess its implantable device, with the aforementioned University Health Network hospital selected as the trial site. Recently, the US Food and Drug Administration granted the company's brain-computer interface breakthrough device designation for treating individuals with severe speech impairment. "Neuralink secures $650m in Series E to advance brain implant technology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Business
- Yahoo
Neuralink secures $650m in Series E to advance brain implant technology
Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant technology. This latest financial boost is aimed at expanding the reach of the company's devices, which are said to restore independence for individuals with severe medical conditions. The round saw contributions from a host of investors, including DFJ Growth, ARK Invest, Founders Fund, Human Capital, G42, Lightspeed, QIA, Thrive Capital, Sequoia Capital, Valor Equity Partners, and Vy Capital. Since its Series D round in August 2023, Elon Musk's Neuralink has been advancing the development of brain interfaces. According to the company, currently, five people with severe paralysis utilise Neuralink's technology to control various digital and physical devices using their thoughts alone. The company's trials are underway at neurosurgical care institutions across three countries on two continents. These comprise the Miami Project to Cure Paralysis at the University of Miami, US, the Barrow Neurological Institute, US, the Cleveland Clinic Abu Dhabi, and the University Health Network (Toronto Western Hospital), Canada. Neuralink invested in enhancing the device's interaction with a greater number of neurons and brain areas to unveil new potential dimensions. The fresh funding is set to expedite the company's drive to broaden access to patients and develop future solutions that bridge the gap between biological intelligence and AI. Musk has shifted focus back to his ventures, including Neuralink, Tesla, SpaceX, and xAI, after stepping down as a special adviser to US President Donald Trump. Last November, Neuralink secured approval for the CONVOY trial to study the brain implant with an assistive robotic arm, alongside the PRIME study in the US. Additionally, Health Canada approved Neuralink's first global trial, CAN-PRIME, to assess its implantable device, with the aforementioned University Health Network hospital selected as the trial site. Recently, the US Food and Drug Administration granted the company's brain-computer interface breakthrough device designation for treating individuals with severe speech impairment. "Neuralink secures $650m in Series E to advance brain implant technology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Entertainment
- Yahoo
Sequins. Feathers. Drama. Bob Mackie Didn't Just Design Clothes — He Created Moments
Sequins. Feathers. Drama. Bob Mackie Didn't Just Design Clothes — He Created Moments originally appeared on L.A. Mag. It's hard to separate Bob Mackie from the legends he's dressed—Elton John, Cher, Diana Ross, Tina Turner, RuPaul Charles, Carol Burnett—but behind every rhinestone and feather lies the vision of an artist who knew, instinctively, how to magnify a person's pure essence through silhouette, shimmer, and new documentary, 'Naked Illusion', Directed by Matthew Miele which is now streaming on PRIME, peels back the rhinestone curtain and reveals the man behind the magic. This isn't just fashion history — it's a glittering masterclass that doesn't just show his work; it shows how his vision helped steer the whole showbiz machine. Trust me, when I say darling, you'll want to watch every fabulous frame! Speaking with him feels like slipping into fashion history. And yet, Bob is anything but stuck in the past. He's warm, sharp, and disarmingly candid. He doesn't just speak in quotes—he tells stories that a deeply personal conversation with me he weaves through his childhood, his creative awakening, his unexpected family revelations, and his thoughts on Pride, Mackie reflects on what it means to be seen and to survive. With humor and grace, the man who defined red carpet magic opens up like never before.'I always knew I was different,' Mackie says from his home in Palm Springs. His voice soft but certain. 'I didn't play the same games as the other boys. I wasn't interested in baseball—I could draw, and that's what I did.' Mackie spent much of his childhood in the company of his British grandmother—no pets, no nonsense—and a boundless imagination. While other kids ran laps, he taped miniature set designs to Coke bottles, staging elaborate fantasy productions with paper dolls and records. 'I would build these little shows on my dresser,' he recalls. 'Play music, change the sets. Then start all over again.'Those daydreams eventually drew him to Hollywood, California, first sketching for other designers before making a name for himself as the go-to for showbiz reinvention.'People say I do 'the Cher look,'' he laughs. 'But Cher is Cher. Diana Ross is Diana. Mitzi Gaynor, totally different. You have to know who you're dressing. Their body, their energy, their essence.'That essence has defined some of fashion's most unforgettable moments. I ask him about the Met Gala, and his eyes light up. '1974. I went with Cher. It was quiet when we walked in… and then, boom. Hundreds of photographers. That dress is still in papers every year.'Even now, he speaks of Cher not just with pride, but with the affection of a creative soulmate. They understood each other without needing to it's not all sequins and applause. In the documentary, Mackie revealed something far more intimate: a granddaughter and two great-granddaughters he never knew he had.'It was a shock,' he says. 'But when I saw their pictures—I thought, they look like my son. They look like me.'He beams as he describes them—smart, sweet, and stylish, with a fondness for vintage shopping and a family full of creative women.'They've got great taste,' he adds, grinning. 'One's even got a stylist aunt in LA.' Mackie isn't interested in slowing down. He's still designing, still dreaming, but these days he chooses his projects carefully—joy is the driver now.'I don't do it every day like I used to,' he says. 'But when I do? I still love it.'And the advice for young designers hoping to follow in his footsteps?'Work for someone whose style you admire. Learn from them. But don't copy them. Find your own voice.'It's the same spirit he instilled in every dress: boldness, individuality, and a belief in the conversation winds down, I share a personal story. About wearing a tuxedo with a half-ballgown to Elton John's Oscar party in LA. About the pride my mother Marianne felt seeing me in the look. About how growing up I would see all of Bob's creations flipping through magazines had inspired it all. 'You wore it,' he smiles. 'That's what matters. You did it. That's the power of clothes.'Bob Mackie gave stars their wings. But perhaps his greatest gift is reminding us that we all deserve to shine. This story was originally reported by L.A. Mag on Jun 1, 2025, where it first appeared.
&w=3840&q=100)
Business Standard
27-05-2025
- Business
- Business Standard
Prime Offices Fund acquires Delhi's Prius Platinum in strategic realty move
Prime Offices Fund (PRIME) — a commercial real estate fund managed by Nuvama and Cushman & Wakefield (NCW) — has acquired Prius Platinum, a premium Grade A office space in South Delhi's high-demand Saket District Centre. The deal comes at a time when India's commercial property sector is gaining attention from both institutional and retail investors for its potential to offer stable, inflation-hedged rental income, especially from marquee properties with long-term tenants. What's the deal? Prius Platinum spans 0.3 million sq. ft. and was previously owned by a consortium led by Kotak Alternate Asset Managers Limited. The property was originally acquired via the Insolvency and Bankruptcy Code (IBC) route in 2021 and has since undergone extensive upgrades, including ESG initiatives, modernisation, and a leasing push. The building is now 95% leased, with a weighted average lease expiry (WALE) of 5 years — a metric that provides comfort to long-term investors seeking predictable income flows. Why this matters for investors? According to Gaurav Puri, Chief Investment Officer at NCW, Prius Platinum fits perfectly into PRIME's vision of creating a sustainable, high-quality, income-generating portfolio. With tenants from legal, pharma, and financial services sectors, the property is positioned to deliver consistent rental yields. From a personal finance perspective, investments in such commercial office spaces — either directly (for high-net-worth individuals) or indirectly via managed funds like PRIME — are becoming a popular hedge against equity market volatility and low-interest fixed deposits. This move also reflects a broader trend of "value creation through transformation" — where distressed or under-utilised assets are revamped to create premium, ESG-compliant commercial hubs. Rahul Chhaparwal, Partner at Kotak Alternate Asset Managers, called the transaction a "testament" to the firm's ability to turn around distressed assets and extract long-term value. He added that the complete revival of Prius Platinum highlights Kotak's sustainability-led asset management strategy. NCW (Nuvama-Cushman JV): A 50:50 joint venture between Nuvama Asset Management (the alternative investment arm of Nuvama Wealth Management Ltd) and Cushman & Wakefield, a global real estate services firm. Their Prime Offices Fund received Sebi approval in 2024 and had its first close in 2025. It targets high-growth office spaces across India. Kotak Alternate Asset Managers Limited: A part of the Kotak Mahindra Group, Kotak Alt has managed over $22 billion across private equity, real estate, infrastructure, and credit. Their real estate vertical focuses on value investing and revival strategies.
&w=3840&q=100)
Business Standard
27-05-2025
- Business
- Business Standard
Prime Fund buys Saket's Prius Platinum office asset from Kotak Alt
PRIME Fund acquires 0.3 million sq ft office space in South Delhi's Saket from Kotak consortium, aiming to build a sustainable, high-yield commercial portfolio Mumbai Prime Offices Fund (PRIME), a commercial real estate-focused fund managed by Nuvama and Cushman & Wakefield Management (NCW), announced the acquisition of Prius Platinum, a grade-A office space in South Delhi's Saket District Centre. The property has been acquired from a fund consortium led by Kotak Alternate Asset Managers (Kotak Alt). PRIME is a 50:50 joint venture between Nuvama Asset Management and Cushman & Wakefield. Spanning across 0.3 million square feet, the property was acquired by the Kotak consortium through the Insolvency and Bankruptcy Code (IBC) process in 2021. The property is 95 per cent leased. It provides rental income with a weighted average lease expiry (WALE) of five years and in-place lock-in periods, assuring long-term income. Gaurav Puri, Chief Investment Officer, NCW, said, 'This rare, institutionally owned asset perfectly aligns with the Prime Offices Fund's strategy of creating a high-quality, sustainable, income-generating portfolio. With India's commercial real estate sector continuing to show strong fundamentals, this acquisition marks an important milestone in delivering world-class investment solutions for our investors.' The asset boasts a tenant stack including leading legal, pharmaceutical and financial institutions in India, as well as other front office tenants. 'This acquisition reinforces Prime Fund's strategy of investing in high-quality office spaces across India's prime commercial hubs,' the fund stated. Rahul Chhaparwal, Partner at Kotak Alternate Asset Managers, said, 'We are proud of the journey this asset has undergone – from acquisition through IBC to a complete revival as a state-of-the-art, ESG-compliant commercial hub. This sale is a testament to the strength of our asset management capabilities and our ability to create long-term value for stakeholders through sustainability-focused strategies.' Besides, the total fund size of PRIME is ₹3,000 crore. The fund achieved its first close at almost ₹1,700 crore in January 2025. Going ahead, it will focus on grade-A 'offices of the future' across the top Indian cities for the fund's deployment.
